QMAIIVMay 21, 2025

An Inclusive Foundation Model for Generalizable Cytogenetics in Precision Oncology

arXiv:2505.15868v12 citationsh-index: 4
Originality Incremental advance
AI Analysis

This addresses the problem of automating cytogenetics for precision oncology, offering a scalable solution to reduce expert annotation workload and improve early detection of rare genomic abnormalities, though it builds incrementally on existing foundation model approaches.

The researchers tackled the challenge of automating chromosome analysis for cancer diagnosis by developing CHROMA, a foundation model that learns generalizable representations of chromosomal abnormalities; it outperformed other methods across all abnormality types, even with fewer labeled data and more imbalanced datasets, using pre-training on over 84,000 specimens (~4 million images).

Chromosome analysis is vital for diagnosing genetic disorders and guiding cancer therapy decisions through the identification of somatic clonal aberrations. However, developing an AI model are hindered by the overwhelming complexity and diversity of chromosomal abnormalities, requiring extensive annotation efforts, while automated methods remain task-specific and lack generalizability due to the scarcity of comprehensive datasets spanning diverse resource conditions. Here, we introduce CHROMA, a foundation model for cytogenomics, designed to overcome these challenges by learning generalizable representations of chromosomal abnormalities. Pre-trained on over 84,000 specimens (~4 million chromosomal images) via self-supervised learning, CHROMA outperforms other methods across all types of abnormalities, even when trained on fewer labelled data and more imbalanced datasets. By facilitating comprehensive mapping of instability and clonal leisons across various aberration types, CHROMA offers a scalable and generalizable solution for reliable and automated clinical analysis, reducing the annotation workload for experts and advancing precision oncology through the early detection of rare genomic abnormalities, enabling broad clinical AI applications and making advanced genomic analysis more accessible.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes